Paper6743508
5-fluorouracil metabolism monitored in vivo by 19F NMR.
Stevens AN and 4 others. Br J Cancer, 1984. Cited by 152 papers, by iCite.
Cite this record
ConductScience Library. 5-fluorouracil metabolism monitored in vivo by 19F NMR. Papers, record 6743508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6743508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluorouracil | Major topic |
| Liver | Major topic |
| Lung Neoplasms | Major topic |
| Animals | |
| Female | |
| Fluorine | |
| Magnetic Resonance Spectroscopy | |
| Mice | |
| Mice, Inbred C57BL |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 476694 | Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver. | Cancer Res | 1979 | https://conductscience.org/library/papers/476694 | PubMed |
| 2 | 7349890 | Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial. | Cancer Res | 1980 | https://conductscience.org/library/papers/7349890 | PubMed |
| 3 | 7357507 | Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU)RNA. | Cancer | 1980 | https://conductscience.org/library/papers/7357507 | PubMed |
| 4 | 6929529 | Methotrexate-induced misincorporation of uracil into DNA. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6929529 | PubMed |
| 5 | 6785851 | Studies of analogs of fluorinated pyrimidine in Japan. | Recent Results Cancer Res | 1981 | https://conductscience.org/library/papers/6785851 | PubMed |
| 6 | 7273010 | Chemotherapy for colorectal cancer with a combination of PALA and 5-FU. | Cancer Treat Rep | 1981 | https://conductscience.org/library/papers/7273010 | PubMed |
| 7 | 7292005 | In vivo carbon-13 nuclear magnetic resonance studies of mammals. | Science | 1981 | https://conductscience.org/library/papers/7292005 | PubMed |
| 8 | 6272993 | An update on the biochemistry of 5-fluorouracil. | Cancer Treat Rev | 1981 | https://conductscience.org/library/papers/6272993 | PubMed |
| 9 | 6459042 | Methods for the complete analysis of 5-fluorouracil metabolites in cell extracts. | Anal Biochem | 1981 | https://conductscience.org/library/papers/6459042 | PubMed |
| 10 | 6211226 | Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas. | Cancer Res | 1982 | https://conductscience.org/library/papers/6211226 | PubMed |
| 11 | 7085662 | Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. | J Biol Chem | 1982 | https://conductscience.org/library/papers/7085662 | PubMed |
| 12 | 6134191 | 31P-NMR studies of a human tumour in situ. | Lancet | 1983 | https://conductscience.org/library/papers/6134191 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 152 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33456555 | In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy. | Theranostics | 2021 | https://conductscience.org/library/papers/33456555 | PubMed |
| 33374213 | Repurposing Clinical Agents for Chemical Exchange Saturation Transfer Magnetic Resonance Imaging: Current Status and Future Perspectives. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33374213 | PubMed |
| 30498886 | Fluorine polymer probes for magnetic resonance imaging: quo vadis? | MAGMA | 2019 | https://conductscience.org/library/papers/30498886 | PubMed |
| 29318102 | Extending the Scope of 19F Hyperpolarization through Signal Amplification by Reversible Exchange in MRI and NMR Spectroscopy. | ChemistryOpen | 2018 | https://conductscience.org/library/papers/29318102 | PubMed |
| 24920908 | Preclinical studies of N₃-O-toluyl-fluorouracil-loaded lipid-based nanosuspensions in H₂₂-bearing mice. | Int J Nanomedicine | 2014 | https://conductscience.org/library/papers/24920908 | PubMed |
| 24363044 | Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization. | Chem Soc Rev | 2014 | https://conductscience.org/library/papers/24363044 | PubMed |
| 22004946 | Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches. | Cancer Biol Ther | 2011 | https://conductscience.org/library/papers/22004946 | PubMed |
| 20886263 | The unique potential for noninvasive imaging in modernizing drug development and in transforming therapeutics: PET/MRI/MRS. | Pharm Res | 2011 | https://conductscience.org/library/papers/20886263 | PubMed |
| 20842758 | Fluorine (19F) MRS and MRI in biomedicine. | NMR Biomed | 2011 | https://conductscience.org/library/papers/20842758 | PubMed |
| 20821329 | Can localised (19)F magnetic resonance spectroscopy pharmacokinetics of 5FU in colorectal metastases predict clinical response? | Cancer Chemother Pharmacol | 2011 | https://conductscience.org/library/papers/20821329 | PubMed |
| 19253373 | Monitoring of release of cargo from nanocarriers by MRI/MR spectroscopy (MRS): significance of T2/T2* effect of iron particles. | Magn Reson Med | 2009 | https://conductscience.org/library/papers/19253373 | PubMed |
| 18661431 | Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence protein. | Acta Oncol | 2008 | https://conductscience.org/library/papers/18661431 | PubMed |
| 16163381 | Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit. | Gene Ther | 2006 | https://conductscience.org/library/papers/16163381 | PubMed |
| 14753189 | [Magnetic resonance imaging spectroscopy. Part 1: Basics]. | Radiologe | 2003 | https://conductscience.org/library/papers/14753189 | PubMed |
| 14583786 | Non-invasive 19F MR spectroscopy of 5-fluorocytosine to 5-fluorouracil conversion by recombinant Salmonella in tumours. | Br J Cancer | 2003 | https://conductscience.org/library/papers/14583786 | PubMed |
| 12915890 | Correlation between 5-fluorouracil metabolism and treatment response in two variants of C26 murine colon carcinoma. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12915890 | PubMed |
| 12889737 | Noninvasive methods to study drug distribution. | Invest New Drugs | 2003 | https://conductscience.org/library/papers/12889737 | PubMed |
| 12448653 | Does leucovorin alter the intratumoral pharmacokinetics of 5-fluorouracil (5-FU)? A Southwest Oncology Group study. | Invest New Drugs | 2002 | https://conductscience.org/library/papers/12448653 | PubMed |
| 12407448 | Enhanced uptake of ifosfamide into GH3 prolactinomas with hypercapnic hyperoxic gases monitored in vivo by (31)P MRS. | Neoplasia | 2002 | https://conductscience.org/library/papers/12407448 | PubMed |
| 8422689 | Prolonged retention of high concentrations of 5-fluorouracil in human and murine tumors as compared with plasma. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8422689 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6743508
GET https://conductscience.org/api/papers/v1/6743508/cited_by?page=2